foxo4 dri human trials results The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI FOXO4-DRI regulates endothelial cell senescence
Description
Structural design Design delivery systems with specific structures and morphologies, such as multilayer nanoparticles or core-shell structured microspheres, to achieve pulsed or targeted drug release
Kopp, J
Who is at Risk for Shingles
Froese DS, Fowler B, Baumgartner MR
10.1016/j.cellsig.2007.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar] Liu X
